Log In
BCIQ
Print this Print this
 

tenatoprazole (sTU-199)

  Manage Alerts
Collapse Summary General Information
Company Mitsubishi Tanabe Pharma Corp.
DescriptionProton pump inhibitor
Molecular Target H+/K ATPase pump
Mechanism of ActionH+/K+ ATPase pump inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationGastroesophageal reflux disease (GERD)
Indication DetailsTreat gastroesophageal reflux disease (GERD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today